P3 Health Partners
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of P3 Health Partners generated cash of -$76,028,000, which is less than the previous year. Cash used in financing activities reached the amount of $100,332,000 last year. Net change in cash is therefore $22,477,000.
Cash Flow
| 2018 | -29.23M | -4.59M | 33.25M |
|---|---|---|---|
| 2019 | -28.28M | -3.85M | 63.61M |
| 2020 | -24.59M | -3.16M | 34.76M |
| 2021 | -66.47M | -56.06M | 223.46M |
| 2022 | -126.01K | -7.73K | 11.37K |
| 2023 | -76.02M | -1.82M | 100.33M |
PIIIW Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 18.45M | 140.83K | 39.90M | 32.90M | 1.42M | 2.01M |
Operating activities | ||||||
Net income | -57.77M | -1.56M | -156.48M | -45.38M | -41.97M | -49.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 86.67M | 87.28K | 8.72M | 795.17K | 399.17K | 342.19K |
Stock-based compensation expense | 5.97M | 19.40M | 8.33M | 447.47K | 474.04K | 0 |
| Deferred income tax benefit | 5.97M | 19.40M | 8.33M | 447.47K | 474.04K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -41.99M | -5.33M | 448.14K | 139.21K | 424.13K | -1.38M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 64.17M | 6.08K | 68.75M | 8.10M | 803.50K | 2.11M |
Cash generated by operating activities | -76.02M | -126.01K | -66.47M | -24.59M | -28.28M | -29.23M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.82M | -2.23K | -3.41M | -2.92M | -1.45M | -3.30M |
Acquisitions Net | 0 | -5.5K | -52.86M | -130K | 0 | 0 |
Cash generated by investing activities | -1.82M | -7.73K | -56.06M | -3.16M | -3.85M | -4.59M |
Financing activities | ||||||
Common Stock Issued | 86.59M | 0 | 195.30M | -180K | 62.04M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -180K | 0 | 0 |
Repayments of term debt | 14.10M | 11.37M | -28.15M | -1.49M | 1.57M | 0 |
Cash used in financing activities | 100.33M | 11.37K | 223.46M | 34.76M | 63.61M | 33.25M |
Net Change In Cash | 22.47M | -122.37K | 100.93M | 6.99M | 31.47M | -585.07K |
Cash at end of period | 40.93M | 18.45K | 140.83M | 39.90M | 32.90M | 1.42M |
| Data source | Data source | Data source |